<DOC>
	<DOCNO>NCT01832493</DOCNO>
	<brief_summary>The Sensor Optimization Cardiac Resynchronization Therapy ( CRT ) Response ( SOCR ) Study multicenter , prospective , non-randomized acute feasibility study conduct determine subcutaneous heart sound and/or intracardiac impedance acutely identify optimal atrioventricular ( AV ) pace interval optimal leave ventricular ( LV ) electrodes patient indicated cardiac resynchronization therapy .</brief_summary>
	<brief_title>Sensor Optimization Cardiac Resynchronization Therapy Response</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject must undergo implant new replacement/upgrade Medtronic CRTP CRTD device approve indication . Subject implant implanted right ventricular ( RV ) lead support bipolar pace sensing ( e.g . bipolar pace/sense lead true bipolar defibrillation lead ) Subject ( subject 's legally authorize representative ) must willing give informed consent Subjects must least 18 year age Subject congenital heart disease Subject tachyarrhythmia ( atrial and/or ventricular ) time enrollment cardioversion attempt prior research procedure Subject unstable coronary artery disease Subject undergo transvenous catheterization Subject mechanical tricuspid aortic valve prosthesis history significant structural tricuspid aortic valvular disease Subject require dual chamber cardiac pace single chamber ( ventricular ) pace rest rate control Subject recent echocardiogram ( within prior 6 month ) reveal presence LV thrombus Subject pregnant Subject enrol concurrent study may confound result study without documented preapproval Medtronic study manager</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>